ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Awards & Nominations

Publication Policies and Ethics

Google Scholar citation report

Citations : 4859

Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons

Indexed In

CAS Source Index (CASSI)
Index Copernicus
Google Scholar
Sherpa Romeo
Open J Gate
Genamics JournalSeek
Academic Keys
JournalTOCs
SafetyLit
China National Knowledge Infrastructure (CNKI)
Electronic Journals Library
RefSeek
Hamdard University
EBSCO A-Z
OCLC- WorldCat
SWB online catalog
Virtual Library of Biology (vifabio)
Publons
Geneva Foundation for Medical Education and Research
Euro Pub
ICMJE

Useful Links

Recommended Journals

Related Subjects

Share This Page

Tweets by Addiction_Res

Ma L

Center for Neurobehavioral Research on Addiction, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, USA

Biography

Ma L is a versatile author and has contributed major research works in the field of Addiction Research and Therapy, psychology, and neurology. And has dedicated their major research contributions in the field of Addiction research, Substance-Related Disorders, Psychology, Neurology, Behavioural Science, etc.

Publications

Cardiovascular and Subjective Effects of the Novel Adenosine A_2A ReceptorAntagonist SYN115 in Cocaine Dependent Individuals

A2A receptor antagonists have been proposed as therapeutic tools for dopaminergically-relevant diseases, including Parkinson's disease and substance dependence. The acute subjective and cardiovascular effects of a novel, selective adenosine A2A receptor antagonist (SYN115) were examined. Across an 8-hour experimental testing day, 22 nontreatment se... Read More»

Lane SD, Green CE, Steinberg JL, Ma L, Schmitz JM, Rathnayaka N, Rathnayaka N, Bandak SD, Ferre S and Moeller FG

Research Article: J Addict Res Ther 2012, S1-009

DOI: 10.4172/2155-6105.S1-009

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article